Actemra 160mg, a treatment known scientifically as tocilizumab, represents a potent therapeutical agent primarily employed for the treatment of rheumatoid arthritis. This remarkable agent functions by blocking the activity of interleukin-6 (IL-6), a signaling protein crucial in the inflammatory process. Moreover, Actemra exhibits efficacy in the c